Evaluating a Device for Blocking the Tear Duct
NCT05748951 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33
Last updated 2024-07-30
Summary
Participants will receive a tear duct plug to see if their eye comfort improves.
Conditions
- Dry Eye
Interventions
- DEVICE
-
Canalicular occlusion device
Occlusive device is inserted into the tear duct to block tear drainage
Sponsors & Collaborators
-
AesculaTech, Inc.
lead INDUSTRY
Principal Investigators
-
Francisco Amparo, MD · Independent
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 22 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-07
- Primary Completion
- 2024-02-22
- Completion
- 2024-02-22
Countries
- Mexico
Study Locations
More Related Trials
-
A Study to Evaluate the Safety and Effectiveness of Oculeve Intranasal Lacrimal Neurostimulator in Participants With Dry Eye Syndrome
NCT02680158 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of TearCare System - Long-Term Extension
NCT03804502 ·Status: COMPLETED ·Phase: NA
-
Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator
NCT02526290 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Ocular Comfort With ISTA Tears vs Systane
NCT01650584 ·Status: COMPLETED ·Phase: NA
-
Dry Eye Symptom Relief Assessment With Use of TrueTear in a Controlled Adverse Environment
NCT03097614 ·Status: COMPLETED ·Phase: NA
-
Tear Production by Nasal Neurostimulation Compared to Active Control
NCT02970799 ·Status: COMPLETED ·Phase: NA
-
The Sinopsys Lacrimal Stent for Lacrimal System Repair in Epiphora
NCT02240615 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Lid Margin And Conjunctival Microbial Flora Following Punctum Occlusion
NCT00735865 ·Status: COMPLETED ·Phase: NA
-
Goblet Cell Degranulation Produced by Intranasal Tear Neurostimulator (ITN) in Dry Eye Disease
NCT03827564 ·Status: TERMINATED ·Phase: NA
-
Intra-Nasal Mechanical Stimulation (INMEST) As a Treatment Method for the Relief of Symptoms of Dry Eye
NCT05887336 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Safety and Effectiveness of the Oculeve Intranasal Lacrimal Neurostimulator in Patients With Dry Eye
NCT02313454 ·Status: COMPLETED ·Phase: NA
-
Assessing the Impact of Tixel Treatment of Periorbital Wrinkles on Dry Eye Symptoms and Signs
NCT04730336 ·Status: COMPLETED ·Phase: NA
-
Study for Remote Investigation of Evaporative Dry Eye Disease
NCT06976515 ·Status: RECRUITING
-
Evaluating Impact of Systane iLux on Dryness Symptoms and Wearing Time in Contact Lens Users
NCT05306561 ·Status: RECRUITING ·Phase: NA
-
Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease
NCT03492541 ·Status: COMPLETED ·Phase: NA
-
TearCare System to Treat Dry Eye Disease
NCT03857919 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Dry Eye Symptoms in CAE With Application of Intranasal Neurostimulation
NCT02910713 ·Status: COMPLETED ·Phase: NA
-
Prospective Evaluation of Efficacy and Safety of an Intense Pulsed Light Device to Treat Dry Eye Disease"
NCT06349356 ·Status: COMPLETED ·Phase: NA
-
Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
NCT02798289 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye
NCT00514852 ·Status: COMPLETED ·Phase: NA
-
Intense Pulsed Light Therapy in Meibomian Gland Dysfunction
NCT04904874 ·Status: UNKNOWN ·Phase: NA
-
An Evaluation of the Clinical Utility and Safety of the Visant Medical Canalicular Plug
NCT04817085 ·Status: COMPLETED ·Phase: NA
-
to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction
NCT05162261 ·Status: COMPLETED ·Phase: NA
-
iTear Single-center, Open-label, Single-arm Study
NCT06525961 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Usability, Immediate, and 30 Day Effect of External Neuromodulation With iTEAR100 Generation 2 in Dry Eye Patients
NCT05304637 ·Status: UNKNOWN ·Phase: PHASE4